
Paxlovid reduces serious risks from Omicron variants
As we continue to navigate the evolving landscape of COVID-19, new data shows promising strides in protecting vulnerable populations, especially older adults, from serious outcomes. A recent study led by researchers at Brigham & Women’s Hospital reveals that Paxlovid, a combination antiviral treatment, significantly reduces the risk of hospitalization and death due to COVID-19 caused
Continue Reading